We’re proud to be featured in the latest edition of International Tobacco Journal!

BioResearch Group (BRG) supports the tobacco industry with clinical research services tailored to the development and validation of new and existing products.

 

  • Our dedicated clinical site offers:
  • Expertise in nicotine and novel tobacco product studies
  • Safety and risk assessments
  • Consumer acceptance evaluations
  • Pharmacokinetic & pharmacodynamic research

 

With 25+ years of experience, a GCLP-certified team and in-house infrastructure, BRG is open and ready to support innovative, responsible tobacco research – globally.

Let’s talk if you're looking for a trusted partner for clinical trials in this area.

Go back

News

Increasing Access to Breakthrough Clinical Trials for Patients in Poland

Poland is strengthening its position as one of the leading clinical research hubs in Europe

Read more …

Happy Easter from BioResearch Group

On the occasion of Easter, we would like to extend our warmest wishes of peace, joy, and renewed energy

Read more …

Clinical research reshapes nicotine regulation – new publication by BRG CEO

BioResearch Group (BRG) announces the publication of a new article by Dr Katarzyna Jarus-Dziedzic.

Read more …

BRG’s Contribution to the Advancement of an Innovative Therapy

Phase I clinical trials conducted at BRG play a key role in the development of new therapies

Read more …

About Us | Services | Our Site | Partners | Smoking Risk Study | Contact Us

Early Phase Clinical Trials

2026 © Bio Research Group. All rights reserved.

 

scroll to top ▲